Latest reported quarter: Q2, ended Jul 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Diluted EPS | $0.82 | $0.56 | $0.65 | -$0.26 | $0.03 |
| Other Income (Expense) | -$281,000.00 | -$109,000.00 | $176,000.00 | -$32.46M | $190,000.00 |
| Other Non-Operating Income (Expenses) | -$281,000.00 | -$109,000.00 | $176,000.00 | $185,000.00 | $190,000.00 |
| Pretax Profit | $37.85M | $24.79M | $32.24M | -$12.32M | $1.85M |
| Tax | $2.79M | -$755,000.00 | $2.63M | -$1.23M | $537,000.00 |
| Net Profit | $35.06M | $25.54M | $29.62M | -$11.10M | $1.31M |
| Profit from Continuing Operations | $35.06M | $25.54M | $29.62M | -$11.10M | $1.31M |
| Net Income to Parent Company | $35.06M | $25.54M | $29.62M | -$11.10M | $1.31M |
| Net Income to Common Stockholders | $35.06M | $25.54M | $29.62M | -$11.10M | $1.31M |
| Total Other Finance Costs | $2.33M | $2.34M | $3.39M | $2.92M | $3.10M |
| Net Non-Operating Interest Income (Expense) | -$2.33M | -$2.34M | -$3.39M | -$2.92M | -$3.10M |
| Total Revenue as Reported | $259.96M | $230.62M | $240.07M | $211.45M | $204.68M |
| Total Operating Revenue | $259.96M | $230.62M | $240.07M | $211.45M | $204.68M |
| Cost of Revenue | $173.06M | $155.49M | $160.10M | $146.94M | $151.85M |
| Gross Profit | $86.90M | $75.13M | $79.97M | $64.51M | $52.83M |
| Operating Expense | $46.43M | $47.90M | $44.51M | $41.46M | $48.07M |
| Selling and Admin Expenses | $35.56M | $35.81M | $33.88M | $31.25M | $36.50M |
| Research & Development | $10.87M | $12.09M | $10.63M | $10.21M | $11.57M |
| Operating Profit | $40.47M | $27.23M | $35.46M | $23.06M | $4.76M |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic EPS | $0.82 | $0.59 | $0.69 | -$0.26 | $0.03 |
| -Less:Other Special Charges | – | – | $0.00 | $32.64M | – |
| Special Income (Charges) | – | – | $0.00 | -$32.64M | – |
No comments yet — be the first to weigh in on ATRO.